Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

A peptoid antagonist of VEGF receptor 2 recognizes a 'hotspot' in the extracellular domain distinct from the hormone-binding site.

Udugamasooriya DG, Ritchie C, Brekken RA, Kodadek T.

Bioorg Med Chem. 2008 Jun 15;16(12):6338-43. doi: 10.1016/j.bmc.2008.05.015. Epub 2008 May 9.

3.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
4.

Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.

Shibuya M.

J Biochem Mol Biol. 2006 Sep 30;39(5):469-78. Review.

PMID:
17002866

Supplemental Content

Write to the Help Desk